Laboratory Services
Qeen Biotechnologies provides specialized laboratory services to support clinical trials with a phage component. Our extensive experience enables us to offer crucial analytical services that ensure the success and compliance of your trials.
We conduct testing via CLSI broth microdilution, the gold standard method for determining the effectiveness of antimicrobial agents against specific bacterial strains.
Our expert team assesses the efficacy of bacteriophages against target bacterial strains, crucial for selecting appropriate phages for therapeutic applications.
We offer accurate quantification of both bacteria and phages in patient specimens, essential for monitoring phage therapy progression and treatment efficacy.
We conduct rigorous stability testing to ensure phage preparations maintain their potency and efficacy throughout the clinical trial, adhering to regulatory requirements.
By leveraging Qeen Biotechnologies’ specialized lab services, researchers and pharmaceutical companies can enhance the quality and reliability of their bacteriophage clinical trials. Our expertise in phage-specific analytical methods provides the necessary support to advance innovative phage-based therapies from conceptualization to clinical application.